人类疱疹病毒8 ORF62抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 人类疱疹病毒8 ORF62抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Kaposi's sarcoma-associated herpesvirus (KSHV) belongs to the gamma-(2)-herpesvirus subfamily and has been closely linked to the Kaposi's sarcoma, primary effusion lymphoma (PEL) and multicentric Castleman's disease. The genome of KSHV is 165-170 kb and contains at least 88人类疱疹病毒8 ORF62抗体 open reading frames. At least five major proteins are likely to be involved in the assembly of the HHV-8 capsid, including a protease (encoded by ORF17), the major capsid protein (encoded by ORF25), and three other smaller capsid proteins (encoded by ORF62, ORF26, and ORF65). Previous structural studies have shown that the HSV-1 triplex is a monomer of VP19c and a dimer of VP23 and that the HCMV triplex is similarly composed of a monomer and a dimer. By人类疱疹病毒8 ORF62抗体 analogy, the KSHV triplexes are likely also composed of a monomer of the ORF62 protein and a dimer of the ORF26 protein, which are the respective homologs of VP19c and VP23.

人类疱疹病毒8 ORF62抗体Also known as:

HHV8; Human herpes virus 8; VP19_HHV8P; Kaposi's sarcoma associated herpesvirus; KSHV; ORF62.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human herpesvirus 8.

●

Immunogen: KLH conjugated synthetic peptide derived from human HHV8 ORF.

●

人类疱疹病毒8 ORF62抗体Predicted Molecular Weight: 36kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl134Hu01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Mu01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Po01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Ra01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Rb51肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Si01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl135Bo01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Ca01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Ga01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Hu01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Mu01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Po01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Ra01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl139Ca01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl139Hu01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl139Mu01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl139Ra01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl140Bo01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Ga01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Hu01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Mu01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Po01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Ra01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)